Psychotropic Medication and Psychosocial Service Use Among Transition Age Youth With Autism Spectrum Disorder.
Autism-only teens usually get pills alone; add a second label to unlock therapy.
01Research in Context
What this study did
The team looked at 1,245 transition-age youth with autism. All were 16-26 years old and on Medicaid.
They checked who got only pills, who got therapy, and who got both. They also noted any second mental-health label like anxiety or ADHD.
What they found
One in three youth with autism-only got pills and no therapy. When a second label was added, therapy was added too.
In short, no extra label equals meds alone. An extra label equals meds plus therapy.
How this fits with other research
Scior et al. (2023) show parent training helps kids with autism eat better, yet many teens still get only meds. The new data say the gate is the second label.
McAuliffe et al. (2017) and Chan et al. (2018) both found social-skills groups help teens with autism, but those groups start only after a second label opens the door.
Cary et al. (2024) remind us to ask the teen directly about social goals. If the teen wants help but has no second label, the chart may still say meds only.
Why it matters
If your client has autism alone, expect the plan to start and stay with medicine. You may need to fight for ABA, social-skills groups, or parent training. Ask the doctor to add a second label when it fits. That small line in the chart can unlock hours of therapy.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Check the axis list in the chart; if only autism is listed, call the psychiatrist to discuss adding anxiety or ADHD when appropriate.
02At a glance
03Original abstract
People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition.
American journal on intellectual and developmental disabilities, 2024 · doi:10.1352/1944-7558-129.1.1